Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?

Tumay Ak,Leyla Mustafayeva,Yeliz Celik,Ali Yagiz Ayla,Serdal Ugurlu

Reumatología Clínica（2022）

Cited 0|Views1
No score
Abstract
Our study's efficacy and safety data on the use of SEC were reassuring in both anti-TNFα naïve and anti-TNFα experienced patients. However, further studies are still needed to determine the appropriate timing to begin SEC treatment.
More
Translated text
Key words
Anti-IL17A,Anti-TNFα,BASDAI score,Espondiloartropatía,Experienced,Experimentado,Naïve,Puntuación BASDAI,Secukinumab,Spondyloarthropathy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined